跳至主要内容
临床试验/JPRN-UMIN000007482
JPRN-UMIN000007482已完成未知

ow dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy - Low dose of Intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy

Division of Ophthalmology, Department of Visual Sciences, Surugadai-Hospital, Nihon University.0 个研究点目标入组 60 人开始时间: 2012年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who had undergone intraocular surgery or retinal photocoagulation within 6 months before the study, and those who had undergone intravitreal injection of drugs or sub-Tenon injection of steroids within 6 months before the study were excluded.

研究者

发起方
Division of Ophthalmology, Department of Visual Sciences, Surugadai-Hospital, Nihon University.

相似试验